Recent Finacing
Recent Raise
Redpin Therapeutics is a preclinical gene therapy company developing varenicline‑activated chimeric ligand‑gated ion channels to selectively activate or silence neurons for epilepsy, neuropathic pain, and Parkinson’s disease.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
